Mast cell activation may explain many cases of chemical intolerance
نویسندگان
چکیده
Abstract Background This paper explores the relationship between chemical intolerance (CI) and mast cell activation syndrome (MCAS). Worldwide observations provide evidence for a two-stage disease process called toxicant-induced loss of tolerance (TILT) as mechanism CI. TILT is initiated by major exposure event or series lower-level exposures. Subsequently, affected individuals report that common inhalants, foods, drugs (i.e., various xenobiotics) trigger multi-system symptoms. Purpose To determine whether MCAS provides plausible biological CI/TILT. Methods Using validated Quick Environmental Exposure Sensitivity Inventory (QEESI), we compared patients diagnosed with ( n = 147) to who reported intolerances (CI/TILT) following exposures 345) healthy controls 76). ANOVA, QEESI scores across groups. Clinical patient group were used predict CI status using logistic regression. Results More than half (59%) met criteria A regression model illustrates likelihood having increased, their CI/TILT similarly near-perfect correspondence at high ends clinical scores. Symptom patterns nearly identical Discussion We present data suggesting xenobiotic cells may underlie The strikingly similar symptom suggest xenobiotics disrupt cells, leading either both these challenging conditions. Faced suffering from complex illness affecting multiple organ systems fluctuating inflammatory, allergic, dystrophic symptoms, clinicians can now ask themselves two questions: (1) Could be root problems? (2) environmental driving MC mediator release? Increasing our understanding connection MCs has potential expose new link illness, offering opportunities improving individual public health. Conclusion close supports xenobiotic-driven release MCAS) unifying CI/TILT, profound implications medicine, health, regulatory toxicology.
منابع مشابه
Idiopathic Mast Cell Activation Syndrome With Associated Salicylate Intolerance
1 Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich Alexander University ErlangenNuremberg, Erlangen, Germany, 2 Medical Clinic II, Waldkrankenhaus, Erlangen, Germany, 3 Medical Clinic III for Rheumatology and Immunology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany, 4 Institute of Pathology, Friedrich...
متن کاملMast cell activation syndrome
www.amepc.org/tau © Translational Andrology and Urology. All rights reserved. It has been over 30 years since the Interstitial Cystitis Association of America (ICA) was established in 1984. Although a great deal more is understood about interstitial cystitis/bladder pain syndrome (IC/BPS), the cause and cure of this condition remains unknown. One hypothesis regarding etiology that appears to ha...
متن کاملExpanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
BACKGROUND In recent years, 2 new syndromes of mast cell activation have been described in patients with episodes of mast cell mediator release that range from flushing and abdominal cramping to anaphylaxis: monoclonal mast cell activation syndrome (MMAS) and idiopathic mast cell activation syndrome (MCAS). OBJECTIVE This review will discuss these 2 new syndromes in the larger context of mast...
متن کاملSpectrum of mast cell activation disorders.
Mast cell (MC) activation disorders present with multiple symptoms including flushing, pruritus, hypotension, gastrointestinal complaints, irritability, headaches, concentration/memory loss and neuropsychiatric issues. These disorders are classified as: cutaneous and systemic mastocytosis with a c-kit mutation and clonal MC activation disorder, allergies, urticarias and inflammatory disorders a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Environmental Sciences Europe
سال: 2021
ISSN: ['2190-4715', '2190-4707']
DOI: https://doi.org/10.1186/s12302-021-00570-3